Please login to the form below

Not currently logged in
Email:
Password:

Chiltern International lines up Dr Jim Esinhart as next CEO

He will replace Glenn Kerkhof from November 1, 2012

Chiltern International has selected Dr Jim Esinhart to be its next CEO with effect from November 1, 2012.

He will replace Glenn Kerkhof, who is stepping down as CEO of the London-based contract research organisation (CRO) after six years in the post.

Kerkhof will relocate to his native Australia to lead Chiltern's owner Czura Thornton in Asia Pacific, but will join Chiltern's board of directors.

Chiltern's new CEO Dr Esinhart has been with the company for six years and is currently senior executive vice president of global scientific services.

Kerkhof said: “I am delighted to have played my part in the development of Chiltern as a leading mid-tier CRO. Chiltern now employs more than 1,400 people in 34 countries, is financially very strong and is poised for substantial growth.

“I am also delighted to see the CEO position transition to a valued and trusted colleague in Jim Esinhart, who I know will bring a tremendous amount to the role. And I very much look forward to contributing to Chiltern's future as a member of the Board based in the Asia Pacific region.”

9th October 2012

From: PME

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....
The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access....

Infographics